Clinical Trial Update: R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating R101933 in combination with chemotherapy for metastatic breast cancer that has not responded to prior chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• R101933

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED